[Acral-lentiginous melanoma: the newest subgroup of malignant melanomas of the skin].
A new subgroup of malignant melanoma, acral-lentiginous melanoma (ALM), is presented, which the authors have diagnosed in 8% of their melanoma patients. In a retrospective study the clinical and pathological findings in 44 patients with ALM are reviewed. A relationship was found between age, tumor diameter and thickness, pigmentation, ulceration, vasoinvasion and mitoses. The author's patients had a 5-year survival rate of 58%.
D000328:Adult; D000368:Aged; D006801:Humans; D007911:Lentigo / Q000473:pathology* / Q000601:surgery; D008545:Melanoma / Q000473:pathology* / Q000601:surgery; D008875:Middle Aged; D011379:Prognosis; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000473:pathology* / Q000601:surgery
Das akral-lentiginöse Melanom: die jüngste Sonderform des malignen Melanoms der Haut.